The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EBMT 2016 | Predicting and diagnosing TB and CMV in hematopoietic cell transplant recipients
Roy Chemaly, MD, from the University of Texas MD Anderson Cancer Center, Houston, TX, USA, provides an overview of an symposium on the role of tuberculosis (TB) and cytomegalovirus (CMV) immunodiagnostics in hematopoietic cell transplant recipients. The theme of the symposium was to look at immunotesting, specifically the T-SPOT.TB and T-SPOT.CMV assays, and how they can help to better predict and diagnose TB and CMV in patients.
Recorded at the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) in Valencia, Spain.
